Special Issue "New Approaches in Radiation Oncology"
Deadline for manuscript submissions: 31 March 2024 | Viewed by 87
2. Director Diagnostic and Therapeutic Department, Chief of Radiation Oncology, General Regional Hospital "F. Miulli", Acquaviva delle Fonti, BA, Italy
Interests: radiation therapy for primary and secondary brain tumors, breast and prostate cancer; high tech radiotherapy (including radiosurgery and stereotactic radiotherapy); ablative radiation (including cardiac radioablation)
Radiation oncology stands at the forefront of personalized medicine, where cutting-edge innovations are reshaping the landscape of cancer treatment and not only. This Special Issue serves as a beacon guiding us through the exciting developments that are revolutionizing the way we cure patients.
Our goal is to showcase the latest innovations in radiation oncology, ranging from advanced imaging technologies and precision treatment planning to the integration of artificial intelligence. We are particularly interested in how these approaches can be tailored to meet the unique needs of individual patients.
This Special Issue will delve into the significance of biomarkers, genomics, and patient-centric care in predicting treatment outcomes and minimizing side effects. Authors are encouraged to contribute research, reviews, and perspectives that shed light on the transformative potential of personalized medicine within the realm of radiation oncology.
Dr. Alba Fiorentino
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- stereotactic radiotherapy